Quality of life in pediatric patients on a paracorporeal ventricular assist device with a novel mobile driving system.

ABSTRACT:

Background

EXCOR ventricular assist device (VAD) is the gold standard circulatory support for children with end-stage heart failure. Until recently, the only available driving unit was the stationary Ikus. This study (NCT04634708) investigates the impact of the novel mobile EXCOR Active driving unit on patients' mobility and the quality of life (QoL) of their families.

Methods

Children on EXCOR VAD support with the Ikus who were mobilizable outside the hospital room were eligible for the prospective study. Patients remained on Ikus for 7 days, then switched to Excor Active, and were observed for another 45 days. The end-points were the rates of clinically relevant device exchanges (i.e., exchanges that could raise safety concerns for the patient) and successful patient outco

SUBMITTER: Miera O 

PROVIDER: S-EPMC11935330 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature